{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:47:37Z","timestamp":1789055257081,"version":"build-2803163510"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Neonatal hypoglycemia affects up to 15% of all newborns. Despite the high prevalence there is no uniform definition of neonatal hypoglycemia, and existing guidelines differ significantly in terms of when and whom to screen for hypoglycemia, and where to set interventional thresholds and treatment goals. In this review, we discuss the difficulties to define hypoglycemia in neonates. Existing knowledge on different strategies to approach this problem will be reviewed with a focus on long-term neurodevelopmental outcome studies and results of interventional trials. Furthermore, we compare existing guidelines on the screening and management of neonatal hypoglycemia. We summarize that evidence-based knowledge about whom to screen, how to screen, and how to manage neonatal hypoglycemia is limited \u2013 particularly regarding operational thresholds (single values at which to intervene) and treatment goals (what blood glucose to aim for) to reliably prevent neurodevelopmental sequelae. These research gaps need to be addressed in future studies, systematically comparing different management strategies to progressively optimize the balance between prevention of neurodevelopmental sequelae and the burden of diagnostic or therapeutic procedures. Unfortunately, such studies are exceptionally challenging because they require large numbers of participants to be followed for years, as mild but relevant neurological consequences may not become apparent until mid-childhood or even later. Until there is clear, reproducible evidence on what blood glucose levels may be tolerated without negative impact, the operational threshold needs to include some safety margin to prevent potential long-term neurocognitive impairment from outweighing the short-term burden of hypoglycemia prevention during neonatal period.<\/jats:p>","DOI":"10.3389\/fendo.2023.1179102","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T02:17:55Z","timestamp":1686190675000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Neonatal hypoglycemia: lack of evidence for a safe management"],"prefix":"10.3389","volume":"14","author":[{"given":"Marcia","family":"Roeper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"Hoermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"B1","article-title":"The surgical therapy of hyperinsulinismus","volume":"3","author":"Whipple","year":"1938","journal-title":"J Int Chir"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1410","article-title":"Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline","volume":"94","author":"Cryer","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-016-4146-6","article-title":"Glucose concentrations of less than 3.0 mmol\/l (54 mg\/dl) should be reported in clinical trials: a joint position statement of the American diabetes association and the European association for the study of diabetes","volume":"60","year":"2017","journal-title":"Diabetologia"},{"key":"B4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jpeds.2022.02.045","article-title":"Reliability and observer dependence of signs of neonatal hypoglycemia","volume":"245","author":"Hoermann","year":"2022","journal-title":"J Pediatr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-3851","article-title":"Postnatal glucose homeostasis in late-preterm and term infants","volume":"127","author":"Adamkin","year":"2011","journal-title":"Pediatrics"},{"key":"B6","volume-title":"Hypoglycaemia of the newborn: review of the literature","year":"1997"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.03.057","article-title":"Recommendations from the pediatric endocrine society for evaluation and management of persistent hypoglycemia in neonates, infants, and children","volume":"167","author":"Thornton","year":"2015","journal-title":"J Pediatr"},{"key":"B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3476(37)80135-3","article-title":"Hypoglycemia","volume":"11","author":"Hartmann","year":"1937","journal-title":"J pediatrics"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1542\/peds.64.5.613","article-title":"Metabolic fuel and hormone responses to fasting in newborn infants","volume":"64","author":"Stanley","year":"1979","journal-title":"Pediatrics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/000992288302200803","article-title":"The effect of early feeding on plasma glucose levels in SGA infants","volume":"22","author":"Wright","year":"1983","journal-title":"Clin Pediatr (Phila)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2017.06.034","article-title":"What happens to blood glucose concentrations after oral treatment for neonatal hypoglycemia","volume":"190","author":"Harris","year":"2017","journal-title":"J Pediatr"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(86)80588-1","article-title":"Plasma glucose values in normal neonates: a new look","volume":"109","author":"Srinivasan","year":"1986","journal-title":"J Pediatr"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/fn.87.1.f46","article-title":"Plasma glucose levels in term infants who are appropriate size for gestation and exclusively breast fed","volume":"87","author":"Diwakar","year":"2002","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-931912","article-title":"Population meta-analysis of low plasma glucose thresholds in full-term normal newborns","volume":"23","author":"Alkalay","year":"2006","journal-title":"Am J Perinatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jpeds.2020.02.079","article-title":"Glucose profiles in healthy term infants in the first 5 days: the glucose in well babies (GLOW) study","volume":"223","author":"Harris","year":"2020","journal-title":"J Pediatr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2014-306435","article-title":"Lactate, rather than ketones, may provide alternative cerebral fuel in hypoglycaemic newborns","volume":"100","author":"Harris","year":"2015","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms161125939","article-title":"Energy metabolism of the brain, including the cooperation between astrocytes and neurons, especially in the context of glycogen metabolism","volume":"16","author":"Falkowska","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B18","first-page":"6","article-title":"Neurodevelopmental outcome of asymptomatic & symptomatic babies with neonatal hypoglycaemia","volume":"94","author":"Singh","year":"1991","journal-title":"Indian J Med Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1972.tb02642.x","article-title":"Neonatal symptomatic and asymptomatic hypoglycaemia: a follow-up study of 151 children","volume":"14","author":"Koivisto","year":"1972","journal-title":"Dev Med Child Neurol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/adc.63.11.1353","article-title":"Neural dysfunction during hypoglycaemia","volume":"63","author":"Koh","year":"1988","journal-title":"Arch Dis Child"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/000992280504400906","article-title":"Brain imaging findings in neonatal hypoglycemia: case report and review of 23 cases","volume":"44","author":"Alkalay","year":"2005","journal-title":"Clin Pediatr (Phila)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1542\/peds.2007-2822","article-title":"Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia","volume":"122","author":"Burns","year":"2008","journal-title":"Pediatrics"},{"key":"B23","article-title":"Imaging patterns of neonatal hypoglycemia","volume":"19","author":"Barkovich","year":"1998","journal-title":"AJNR Am J Neuroradiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s002470050527","article-title":"Cranial MRI of neurologically impaired children suffering from neonatal hypoglycaemia","volume":"29","author":"Murakami","year":"1999","journal-title":"Pediatr Radiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2005.11.015","article-title":"Neonatal hypoglycemia and occipital cerebral injury","volume":"148","author":"Filan","year":"2006","journal-title":"J Pediatr"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2006.09.011","article-title":"Neurologic outcome in patients with MRI pattern of damage typical for neonatal hypoglycemia","volume":"29","author":"Yalnizoglu","year":"2007","journal-title":"Brain Dev"},{"key":"B27","article-title":"Clinical evaluation by MRI on the newborn infants with hypoglycemic brain damage","volume":"45","author":"Mao","year":"2007","journal-title":"Zhonghua Er Ke Za Zhi."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2002","article-title":"Occipital lobe injury and cortical visual outcomes after neonatal hypoglycemia","volume":"122","author":"Tam","year":"2008","journal-title":"Pediatrics"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-005-0020-2","article-title":"Neonatal hypoglycaemic encephalopathy: diffusion-weighted imaging and proton MR spectroscopy","volume":"36","author":"Kim","year":"2006","journal-title":"Pediatr Radiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/fn.79.2.f145","article-title":"Brain imaging in neonatal hypoglycaemia","volume":"79","author":"Traill","year":"1998","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.102943","article-title":"Associations between neonatal hypoglycaemia and brain volumes, cortical thickness and white matter microstructure in mid-childhood: an MRI study","volume":"33","author":"Nivins","year":"2022","journal-title":"NeuroImage Clin"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.580642","article-title":"Risk factors for adverse neurodevelopment in transient or persistent congenital hyperinsulinism","volume":"11","author":"Roeper","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1530\/eje.0.1490043","article-title":"Long-term follow-up of 114 patients with congenital hyperinsulinism","volume":"149","author":"Meissner","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2013.00060","article-title":"Abnormal neurodevelopmental outcomes are common in children with transient congenital hyperinsulinism","volume":"4","author":"Avatapalle","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2539","article-title":"High risk of diabetes and neurobehavioral deficits in individuals with surgically treated hyperinsulinism","volume":"100","author":"Lord","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00156","article-title":"Both low blood glucose and insufficient treatment confer risk of neurodevelopmental impairment in congenital hyperinsulinism: a multinational cohort study","volume":"8","author":"Helleskov","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.297.6659.1304","article-title":"Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia","volume":"297","author":"Lucas","year":"1988","journal-title":"BMJ"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1159\/000492859","article-title":"Neonatal glycaemia and neurodevelopmental outcomes: a systematic review and meta-analysis","volume":"115","author":"Shah","year":"2019","journal-title":"Neonatology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jpeds.2015.10.066","article-title":"Outcome at 2 years after dextrose gel treatment for neonatal hypoglycemia: follow-up of a randomized trial","volume":"170","author":"Harris","year":"2016","journal-title":"J Pediatr"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2017.1579","article-title":"Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years","volume":"171","author":"McKinlay","year":"2017","journal-title":"JAMA Pediatr"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0992","article-title":"Association of neonatal hypoglycemia with academic performance in mid-childhood","volume":"327","author":"Shah","year":"2022","journal-title":"JAMA"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-020-03729-x","article-title":"Neurodevelopmental outcomes after moderate to severe neonatal hypoglycemia","volume":"179","author":"Rasmussen","year":"2020","journal-title":"Eur J Pediatr"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1905593","article-title":"Lower versus traditional treatment threshold for neonatal hypoglycemia","volume":"382","author":"van Kempen","year":"2020","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2015.1631","article-title":"Association between transient newborn hypoglycemia and fourth-grade achievement test proficiency: a population-based study","volume":"169","author":"Kaiser","year":"2015","journal-title":"JAMA Pediatr"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-018-0425-5","article-title":"Moderate neonatal hypoglycemia and adverse neurological development at 2-6 years of age","volume":"33","author":"Wickstrom","year":"2018","journal-title":"Eur J Epidemiol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.5.1141","article-title":"Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds","volume":"105","author":"Cornblath","year":"2000","journal-title":"Pediatrics"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2010.05.002","article-title":"Describing hypoglycemia\u2013definition or operational threshold","volume":"86","author":"Rozance","year":"2010","journal-title":"Early Hum Dev"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.1996.tb02558.x","article-title":"Definition of neonatal hypoglycaemia: is there a change","volume":"32","author":"Koh","year":"1996","journal-title":"J Paediatr Child Health"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.15337","article-title":"Clinical management and knowledge of neonatal hypoglycaemia in Germany: a national survey of midwives and nurses","volume":"57","author":"Roeper","year":"2021","journal-title":"J Paediatr Child Health"},{"key":"B50","unstructured":"South Australian perinatal practice guideline\n            VargheseJ\n          Government of South AustraliaNeonatal hypoglycaemia: department for health and wellbeing2020"},{"key":"B51","unstructured":"Hypoglycaemia-newborn. guideline no. MN19.8-V12-R24: Queensland health2022"},{"key":"B52","unstructured":"Child and adolescent health service. hypoglycaemia guideline2021"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1055\/a-0621-1369","article-title":"Betreuung von neugeborenen diabetischer m\u00fctter. leitlinie der GNPI, DGPM, DDG, DGHWi, dem DHV, der DGKJ und DGGG.(2k-level, AWMF-Leitlinien-Register nr. 024\/006, juli 2017)","volume":"222","author":"Segerer","year":"2018","journal-title":"Z f\u00fcr Geburtshilfe und Neonatologie"},{"key":"B54","unstructured":"Identification and management of neonatal hypoglycemia in the full term infant framework for practice2017"},{"key":"B55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apa.14955","article-title":"Swedish National guideline for prevention and treatment of neonatal hypoglycaemia in newborn infants with gestational age >\/=35 weeks","volume":"109","author":"Wackernagel","year":"2020","journal-title":"Acta Paediatr"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1089\/bfm.2021.29178.new","article-title":"ABM clinical protocol #1: guidelines for glucose monitoring and treatment of hypoglycemia in term and late preterm neonates, revised 2021","volume":"16","author":"Wight","year":"2021","journal-title":"Breastfeed Med"},{"key":"B57","unstructured":"Prevention and treatment of hypoglycaemia in neonates with a gestational age from 35 0\/7 weeks in maternity wards: Swiss society of neonatology guidelines2020"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.5152\/TurkPediatriArs.2018.01820","article-title":"Management of hypoglycemia in newborn: Turkish neonatal and pediatric endocrinology and diabetes societies consensus report","volume":"53","author":"Aliefendioglu","year":"2018","journal-title":"Turk Pediatri Ars"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/pxz134","article-title":"The screening and management of newborns at risk for low blood glucose","volume":"24","author":"Narvey","year":"2019","journal-title":"Paediatr Child Health"},{"key":"B60","unstructured":"Christchurch Women\u2019s hospital. hypoglycaemia of the newborn2020"},{"key":"B61","unstructured":"Guidance on the development of policies and guidelines for the prevention and management of hypoglycaemia of the newborn: UNICEF London2013"},{"key":"B62","unstructured":"Neonatal hypoglycaemia guideline2021"},{"key":"B63","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.pedneo.2016.12.002","article-title":"Retrospective evaluation of a national guideline to prevent neonatal hypoglycemia","volume":"58","author":"Rasmussen","year":"2017","journal-title":"Pediatr Neonatol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-050733","article-title":"Dextrose gel for neonates at risk with asymptomatic hypoglycemia: a randomized clinical trial","volume":"149","author":"Gupta","year":"2022","journal-title":"Pediatrics"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3233\/NPM-221170","article-title":"Oral dextrose gel use in asymptomatic hypoglycemic newborns decreases NICU admissions and parenteral dextrose therapy: a retrospective study","volume":"16","author":"Parappil","year":"2023","journal-title":"J Neonatal Perinatal Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13052-021-01149-7","article-title":"Management of asymptomatic hypoglycemia with 40% oral dextrose gel in near term at-risk infants to reduce intensive care need and promote breastfeeding","volume":"47","author":"Meneghin","year":"2021","journal-title":"Ital J Pediatr"},{"key":"B67","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/adc.2003.039412","article-title":"Neurodevelopmental outcome of hypoglycaemia in healthy, large for gestational age, term newborns","volume":"90","author":"Brand","year":"2005","journal-title":"Arch Dis Child"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1701193","article-title":"Neonatal polycythemia and hypoglycemia in newborns: are they related","volume":"38","author":"Hopfeld-Fogel","year":"2021","journal-title":"Am J Perinatol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"9616","DOI":"10.3390\/ijerph19159616","article-title":"The risk for neonatal hypoglycemia and bradycardia after beta-blocker use during pregnancy or lactation: a systematic review and meta-analysis","volume":"19","author":"de Bruin","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-1919","article-title":"Neurodevelopment after neonatal hypoglycemia: a systematic review and design of an optimal future study","volume":"117","author":"Boluyt","year":"2006","journal-title":"Pediatrics"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.2456","article-title":"Hypoglycemia in the newborn and neurodevelopmental outcomes in childhood","volume":"327","author":"Rozance","year":"2022","journal-title":"JAMA"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-020-0641-1","article-title":"Clinical impact of neonatal hypoglycemia screening in the well-baby care","volume":"40","author":"Mukhopadhyay","year":"2020","journal-title":"J Perinatol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.1048897","article-title":"Application of the screening test principles to screening for neonatal hypoglycemia","volume":"10","author":"Alsweiler","year":"2022","journal-title":"Front Pediatr"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1159\/000519497","article-title":"The association between serum bilirubin and kernicterus spectrum disorder: a systematic review and meta-analysis","volume":"118","author":"Lai","year":"2021","journal-title":"Neonatology"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-063009","article-title":"Protecting against brain damage by improving treatment in neonates with hypoglycaemia: ProBrain-d-a study protocol of a prospective longitudinal study","volume":"12","author":"Hoermann","year":"2022","journal-title":"BMJ Open"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1179102\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T02:18:04Z","timestamp":1686190684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1179102\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":75,"alternative-id":["10.3389\/fendo.2023.1179102"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1179102","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"article-number":"1179102"}}